<DOC>
	<DOCNO>NCT01444274</DOCNO>
	<brief_summary>This observational , prospective , non-randomized , pilot study gain initial device experience novel space-occupying device person overweight obese . No formal hypothesis test conduct .</brief_summary>
	<brief_title>Pilot Study Evaluate A Novel Gastric Space Occupying Device</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<criteria>1 . Age 2164 year 2 . BMI 2740 Kg/m2 3 . No history weight reduction 5 % total body weight past 6 month 1 . Have unstable angina , myocardial infarction within past year , heart disease classify within New York Heart Association 's Class III IV functional capacity ; 2 . Be take chronic aspirin non steroidal antiinflammatory agent , medication know gastric irritant , unwillingness discontinue use concomitant medication , antiarrythmics , antianginal medication , anticoagulant medication congestive heart failure ; 3 . Be take blood pressure medication , unless blood pressure control stable dose least 3 month ; 4 . Have type 1 diabetes type 2 diabetes require oral medication insulin ; 5 . History symptom thyroid disease control medication ; 6 . Have severe renal , hepatic , pulmonary disease cancer ; 7 . Past history gastrointestinal surgery ( exclude uncomplicated appendectomy ) ; 8 . Have history adhesive peritonitis ; 9 . History symptom esophageal and/or gastric varix ; 10 . Have history congenital acquire GI anomaly ( e.g . atresia , stricture , /or diverticulum ) ; 11 . History symptom inflammatory bowel disease , Chron 's disease ; 12 . History of/ sign /or symptom duodenal gastric ulcer ; 13 . Have gastroparesis ; 14 . Pregnant breastfeeding intention become pregnant study ( female childbearing potential ) ; 15 . Currently use pharmaceutical agent weight loss ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>